Table 1. Drug of choice and time of administration in patients without risk factors for infection.
The table displays the answers from urology departments in Sweden in late 2014 / early 2015 regarding their current use of antibiotic prophylaxes prior to prostate biopsy.
| Question 1a: What prophylaxis is currently used as
standard at your department? | ||
|---|---|---|
| n | % | |
| a. Ciprofloxacin 750 mg x 1 | 50 | 66 |
| b. Ciprofloxacin 500 mg x 1 | 2 | 3 |
| c. Multiple doses of ciprofloxacin (500 or 750 mg) | 14 | 18 |
| d. Trimethoprim-sulfamethoxazole 160/800 mg x 1 | 7 | 9 |
| e. Multiple doses of trimethoprim-sulfamethoxazole | 1 | 1 |
| f. Other, please specify | 2 | 3 |
| Question 2a: At what point do you give the antibiotics to the
patient? | ||
| n | % | |
| a. Immediately before the biopsy | 41 | 54 |
| b. Immediately after the biopsy | 12 | 16 |
| c. More than 1 h prior to the biopsy | 8 | 11 |
| d. Before and after the biopsy | 12 | 16 |
| e. Other, please specify | 1 | 1 |
| Non-responders | 2 | 3 |